• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Theranexus and BBDF Win FDA Approval on Efficacy Endpoints for the Ph III Trial

    ACCESSWIRE

    heranexus and BBDF Win FDA Approval on Efficacy Endpoints for the PhIII Trial

    ACCESSWIRE

    Theranexus, BBDF and Cardiff University Present Their Novel Research on Batten-1

    ACCESSWIRE

    New Advance to the Theranexus& BBDF Batten-1 Program for Juvenile Batten Disease

    ACCESSWIRE

    Theranexus Announces the Success of Its Phase II Trial for THN102

    YAHOO

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.